Article

The Whirlwind of Metastatic Breast Cancer

Author(s):

Editor’s Note: This piece was submitted by a contributing writer and does not represent the views of CURE Media Group.

I am a 47-year-old wife and mother of two daughters, and I have stage 4 metastatic breast cancer. I was diagnosed de novo metastatic disease (which means stage 4 at first diagnosis) on Christmas Day 2014, in an emergency room of a rural town. The shock I felt is indescribable. I never went through early stage cancer, and it was terrifying to hear these exact words from an ER doctor: "I'm so sorry, you are 100 percent riddled with tumors." These were not the words that brought me to my knees. It was the confirmation by an oncologist that did.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.